Background: The sustained virological response (SVR) rate for the 12-week sofosbuvir (SOF)/ledipasvir (LVD) treatment of adolescent genotype-4 patients is high. The aim of this study is to evaluate 8 versus 12-week treatment efficacy and safety in adolescent genotype-4 patients.
Patients And Methods: In total, 157 chronic hepatitis C-infected adolescent patients (mean age 14±2 years, 62% males) were included in this study. All patients received a morning dose of SOF (400 mg)/LVD (90 mg) as a single tablet for 8 and 12 weeks. Laboratory and biochemical monitoring were performed at weeks 4 and 8, end of treatment (8/12) and 12 weeks after the end of treatment (SVR12).
Results: In total, SVR12 was 98% [95% confidence interval (CI): 96-100] for all treated patients. For patients treated for 12 weeks, SVR12 was 97.6% (95% CI: 96-101) (82/84 patients), and 98.6% (95% CI: 93-101) (72/73) patients for those treated for 8 weeks. For both regimens, no serious adverse effects, treatment discontinuation or cases of death were detected. The main adverse effects for the 8-week patient group were fatigue (2.8%), headache (1.4%), nausea (1.4%) and epigastric tenderness (1.4%). For the 12-week-treated group, adverse events were epigastric tenderness (1.2%), nausea (1.2%), diarrhoea (2.4%) and rash (2.4%). Three patients were lost to follow-up: two were in the 12-week treatment group and one was in the 8-week group. All of them reached end of treatment but were lost before SVR12. No relapsers were observed in either group.
Conclusion: Eight weeks of treatment of SOF/LVD combination is equally effective and safe as 12 weeks in adolescent genotype-4 patients.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MEG.0000000000001360 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Association between gene polymorphism and the effects of high-intensity interval training on body composition].
Sheng Li Xue Bao
December 2024
College of Life Sciences, Anqing Normal University, Anqing 246133, China.
This study aimed to analyze the impact of single nucleotide polymorphism (SNP) of (encoding adenylate cyclase 3) on the outcome of high-intensity interval training (HIIT) on body composition and screen genetic markers sensitive to HIIT in Chinese Han youth. A total of 237 non-regular exercise Han college students were recruited in a 12-week HIIT program, attending sessions 3 times a week. Before and after the HIIT program, their body composition was measured.
View Article and Find Full Text PDFEffectiveness and Safety of Glecaprevir/Pibrentasvir in Italian Children and Adolescents With Chronic Hepatitis C: A Real-Word, Multicenter Study.
Liver Int
November 2024
Liver Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
Background & Aims: Glecaprevir/Pibrentasvir (GLE/PIB) has been approved by the European Medicine Agency (EMA) and by the US Food and Drug Administration (US-FDA) for the treatment of children and adolescents from 3 years of age with chronic hepatitis C virus (CHC) infection. The aim of this study was to confirm the real-world effectiveness and safety of GLE/PIB in children and adolescents (3 to < 18 years old) with CHC.
Methods: This prospective, multicentre study involved 11 Italian centres.
[Genetic Analysis of Thalassemia in Children in Liuzhou of Guangxi Zhuang Autonomous Region].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
October 2024
Department of Medical Genetics, Liuzhou Maternity and Child Healthcare Hospital, Liuzhou Key Laboratory of Thalassemia Precise Prevention and Treatment, Guangxi Clinical Research Center for Obstetrics and Gynecology, Liuzhou 545001, Guangxi Zhuang Autonomous Region, China.
Article Synopsis
- The study aimed to analyze the types of thalassemia genes in children aged 1 day to 14 years in Liuzhou, Guangxi, with data collected from 822 suspected cases between January 2019 and April 2022.
- Using Gap-PCR and PCR with reverse dot blot hybridization, researchers found that 68.25% of the children were thalassemia carriers, mainly α-thalassemia, with the most common genotype being --/αα.
- The findings indicate a higher prevalence of α-thalassemia among children, significant rates of moderate to severe thalassemia, and variations in gene distribution between Zhuang and Han ethnic groups.
Diversity, geographical distribution and predictive factors of Hepatitis C virus genotypes and subtypes in Rwanda.
Acta Trop
December 2024
Department of Clinical Microbiology, CHU of Liege, University of Liege - Liege, Belgium. Electronic address:
Background: Existing data on the prevalence of hepatitis C virus (HCV) genotypes and subtypes in Rwanda need to be strengthened. The aim of this study was to identify HCV genotypes and subtypes among HCV-infected patients, as well as their geographical distribution in Rwanda, and to identify the social and economic factors that could influence HCV epidemiology which would make it possible to target national preventive and management actions for infected patients.
Methods: This study included 560 patients with confirmed chronic HCV infection.
A decade-long retrospective study of hepatitis C virus genetic diversity in Cameroon, 2013-2023: presence of a high proportion of unsubtypable and putative recombinant HCV strains.
Arch Virol
September 2024
Department of Virology, Centre Pasteur of Cameroon, 451 Rue 2005, P.O. Box 1274, Yaoundé, Cameroon.
While treatment options for hepatitis C virus (HCV) infection have expanded considerably over the past decade thanks to the development of pan-genotypic therapies, genotype testing remains a prerequisite for treatment in sub-Saharan African countries, including Cameroon, where multiple HCV genotypes and subtypes exist. The main objective of this study was to describe the trend in the distribution of HCV genotypes and subtypes from 2013 to 2023 in the Cameroonian population. Viral loads were determined using the Abbott real-time assay, and genotyping/subtyping was based on nested and semi-nested reverse transcription polymerase chain reaction (RT-PCR) amplification of the regions encoding the core and non-structural protein 5B (NS5B) regions, respectively, followed by sequencing and phylogenetic analysis.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!